Last reviewed · How we verify

NCT04640155

Treating Chronic Pouchitis With a Low FODMAP Diet

Withdrawn NA Last updated 13 February 2023
What this trial tests

NA trial testing Low FODMAP Diet in Pouchitis. Withdrawn.

Timeline
27 October 2020
Primary endpoint
27 October 2022
27 October 2022

Quick facts

Lead sponsorNorthwestern University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date27 October 2020
Primary completion27 October 2022
Estimated completion27 October 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Northwestern University

Who can join

Adults 18 to 65, any sex, with Pouchitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We aim to determine whether low FODMAP diet in patients with chronic pouchitis will improve symptoms and pouch inflammation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Chronic Antibiotic-Refractory Pouchitis: Management Challenges.
    Outtier A, Ferrante M. · · 2021 · cited 6× · PMID 34163205 · DOI 10.2147/ceg.s219556

Verify or expand the search:

Other trials of Low FODMAP Diet

Trials testing the same drug.

Other recruiting trials for Pouchitis

Currently open trials in the same condition.

Other Northwestern University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04640155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing